SEC Tracker
Get the app
MEDS · XBRL financial data

DataMeds AI financial statements, every quarter

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MEDS's year ends in late December)

In thousands of dollarsDec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026†Jun 30, 2026
Revenue from contracts with customersyear only10,8637,7913,0131,671*1,5601,780
Cost of revenueyear only10,1717,2852,7829,526*1,3891,598
Gross profit—693506231(7,856)*170182
General and administrative4,349*31,1734,86030,1734,127*4,8697,057
Total operating expenses4,996*32,0416,00631,77917,496*6,1867,527
Operating income (loss)(3,748)*(31,348)(5,500)(31,548)(25,352)*(6,016)(7,345)
Interest expense689*1,0941,1841,425876*2,0731,561
Net income (loss)(4,332)*(32,431)(6,672)(34,318)(27,853)*(7,743)(18,363)
Earnings per share, basic USD per share(0.09)*(0.62)(0.11)(0.46)—(0.07)(7.13)
Earnings per share, diluted USD per share(0.09)*(0.62)(0.11)(0.46)—(0.07)(7.13)
Weighted average shares, basic thousands of shares49,944*51,91761,77174,379—104,6212,575
Weighted average shares, diluted thousands of shares49,944*51,91761,77174,379—104,6212,575
  • † Share count changed about 1/41 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (MEDS's year ends in late December)

In thousands of dollarsDec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026†Jun 30, 2026
Cash and cash equivalents1,0282,5174204,22943522,456
Accounts receivable————1,1379921,174
Inventory9,5199,7339,0317,4921,6391,7141,510
Total current assets15,16916,55213,51012,8202,8192,7625,633
Property and equipment, net388348309269229202174
Right-of-use asset1,5281,4051,2801,020967844720
Goodwill16,22016,22016,22016,22014,19414,19414,194
Total assets57,33358,06354,22552,78030,45930,12832,759
Current portion of long-term debt11,4556,400—————
Total current liabilities38,04746,22542,40432,74129,78032,19939,414
Long-term debt11,455—10,10012,60012,60012,60012,600
Lease liability, non-current1,096959816660527391250
Total liabilities50,59853,58453,32046,00242,90745,19052,264
Accumulated deficit(9,757)(42,188)(48,861)(83,179)(111,032)(118,774)(137,138)
Total stockholders' equity6,7344,4799056,778(12,448)(15,062)(19,504)
Total liabilities and equity57,33358,06354,22552,78030,45930,12832,759
Common shares outstanding (cover page) thousands of shares51,94471,86184,06489,729104,872125,6713,062
  • † Share count changed about 1/41 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (MEDS's year ends in late December)

In thousands of dollarsDec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026†Jun 30, 2026
Net income (loss)(4,332)*(32,431)(6,672)(34,318)(27,853)*(7,743)(18,363)
Stock-based compensationyear only27,773935*25,730*356*1,3581,205*
Net cash from operating activitiesyear only(1,347)(2,079)*(1,135)*year only(3,413)(2,894)*
Net cash from investing activities803*(273)(132)*(221)*(255)*(205)(242)*
Proceeds from issuing common stockyear only——————
Net cash from financing activities2,056*3,109114*5,165*2,363*3,6275,541*
Net change in cash235*1,488(2,097)*3,809*(4,186)*92,405*
  • † Share count changed about 1/41 in the period ending 2026-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 5122 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 5122 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
DataMeds AI2,4561,780(2,894)*3.1M0.8 quarters 10-QJun 30, 2026
Sharing Services Global7302,085(421)*309,6521.7 quarters 10-QSep 30, 2024
Cosmos Health1,80118,986(1,718)*100.6M1.1 quarters 10-QJun 30, 2026
Stemtech247629(55)*3.0B4.5 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.